COMP <GO>
CHYM vs MS // ENTERPRISE SCALE & MARKET CAP
Chime Financial Inc. (NASDAQ) VS. Morgan Stanley (NYSE) • 15-METRIC TALLY: CHYM 6
— MS 8
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MS
LAST: $27.95 (-3.19%) • MKT CAP: $10.93B
market-cap
$10.93B
LAST: $184.30 (-3.00%) • MKT CAP: $298.41B
market-cap
$298.41B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CHYM VS. MS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CHYM | MS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 88.00% | 41.00% | +47.00 | CHYM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 3.00% | -38.00 | MS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 31.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.42% | -7.25% | +6.83 | CHYM | /fcf-yield <GO> |
| Operating Margin | -47.60% | 24.60% | -72.20 | MS | /operating-margins <GO> |
| Net Profit Margin | -46.20% | 20.20% | -66.40 | MS | /net-margins <GO> |
| Revenue Growth (YoY) | 30.70% | 5.50% | +25.20 | CHYM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.21% | -2.21 | MS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.45 | 0.46 | +8.99 | CHYM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 5/9 | +1.00 | CHYM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 7.00% | -0.40 | CHYM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.3 | 43.3 | -2.04 | MS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 1.04 | -0.13 | MS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.0x | 16.5x | +5.50 | MS | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $10.93B | $298.41B | -$287.48B | MS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CHYM REV | MS REV | CHYM GROSS % | MS GROSS % | CHYM FCF | MS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.19B | $0 | 88.0% | — | -$45.6M | -$17.89B |
| FY 2024 | $1.67B | $0 | 87.6% | — | -$11.2M | $1.36B |
| FY 2023 | $1.28B | $0 | 44.0% | — | -$214.1M | -$33.54B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CHYM // BETA 0.91
MS // BETA 1.04